Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study

MLA

Takehiro Noda, et al. “Clinical Outcomes of Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastasis with Intermediate Risk of Postoperative Recurrence: A Multi‐institutional Retrospective Study.” Annals of Gastroenterological Surgery, vol. 7, no. 3, May 2023, pp. 479–90. EBSCOhost, https://doi.org/10.1002/ags3.12631.

APA

Takehiro Noda, Hidekazu Takahashi, Mitsuyoshi Tei, Naohiro Nishida, Taishi Hata, Yutaka Takeda, Masayuki Ohue, Hiroshi Wada, Tsunekazu Mizushima, Tadafumi Asaoka, Mamoru Uemura, Shogo Kobayashi, Kohei Murata, Taroh Satoh, Yuichiro Doki, Hidetoshi Eguchi, & the Clinical Study Group of Osaka University, C. C. G. and H. G. (2023). Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study. Annals of Gastroenterological Surgery, 7(3), 479–490. https://doi.org/10.1002/ags3.12631

Chicago

Takehiro Noda, Hidekazu Takahashi, Mitsuyoshi Tei, Naohiro Nishida, Taishi Hata, Yutaka Takeda, Masayuki Ohue, et al. 2023. “Clinical Outcomes of Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastasis with Intermediate Risk of Postoperative Recurrence: A Multi‐institutional Retrospective Study.” Annals of Gastroenterological Surgery 7 (3): 479–90. doi:10.1002/ags3.12631.